Definitive Healthcare Corp logo

Definitive Healthcare Corp (DH)

Market Closed
5 Dec, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
2. 48
-0.08
-3.13%
Pre Market
$
2. 82
+0.34 +13.71%
290.28M Market Cap
- P/E Ratio
0% Div Yield
352,020 Volume
0.38 Eps
$ 2.56
Previous Close
Day Range
2.44 2.64
Year Range
2.15 5.68
Want to track DH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 73 days

Summary

DH closed Friday lower at $2.48, a decrease of 3.13% from Thursday's close, completing a monthly decrease of -3.13% or $0.08. Over the past 12 months, DH stock lost -40.38%.
DH is not paying dividends to its shareholders.
The last earnings report, released on Nov 06, 2025, missed the consensus estimates by -0.06%. On average, the company has fell short of earnings expectations by -0.01%, based on the last three reports. The next scheduled earnings report is due on Feb 19, 2026.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

DH Chart

Similar

Enanta Pharmaceuticals Inc.
$ 14.6
+3.62%
Kyverna Therapeutics, Inc.
$ 7.8
-0.51%
Nautilus Biotechnology, Inc.
$ 2.03
-1.93%
Spok Holdings Inc.
$ 13.02
-0.08%
CVRx, Inc.
$ 9.05
-3.21%
Definitive Healthcare Corp. (DH) Q3 2025 Earnings Call Transcript

Definitive Healthcare Corp. (DH) Q3 2025 Earnings Call Transcript

Definitive Healthcare Corp. ( DH ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Jonathan Paris - Chief Legal Officer & Secretary Kevin Coop - CEO & Director Casey Heller - Chief Financial Officer Conference Call Participants Jared Haase - William Blair & Company L.L.C., Research Division Nishad Patwardhan - Goldman Sachs Group, Inc., Research Division Johnathan McCary - Raymond James & Associates, Inc., Research Division Jenny Shen - BTIG, LLC, Research Division David Grossman - Stifel, Nicolaus & Company, Incorporated, Research Division Presentation Operator Welcome to Definitive Healthcare's Q3 2025 Earnings Call.

Seekingalpha | 1 month ago
Definitive Healthcare Corp. (DH) Beats Q3 Earnings and Revenue Estimates

Definitive Healthcare Corp. (DH) Beats Q3 Earnings and Revenue Estimates

Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.1 per share a year ago.

Zacks | 1 month ago
What Makes Definitive Healthcare (DH) a New Buy Stock

What Makes Definitive Healthcare (DH) a New Buy Stock

Definitive Healthcare (DH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 1 month ago

Definitive Healthcare Corp (DH) FAQ

What is the stock price today?

The current price is $2.48.

On which exchange is it traded?

Definitive Healthcare Corp is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is DH.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 290.28M.

What is the earnings per share?

The EPS is 0.06.

When is the next earnings date?

The next earnings report will release on Feb 19, 2026.

Has Definitive Healthcare Corp ever had a stock split?

No, there has never been a stock split.

Definitive Healthcare Corp Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Kevin D. Coop CEO
NASDAQ (NGS) Exchange
24477E103 CUSIP
US Country
782 Employees
- Last Dividend
- Last Split
15 Sep 2021 IPO Date

Overview

Definitive Healthcare Corp. is a trailblazer in delivering software as a service (SaaS) driven healthcare commercial intelligence solutions, catering to a diverse clientele across the United States and globally. Founded in 2011 and based in Framingham, Massachusetts, the company's robust SaaS platform offers invaluable insights into healthcare providers and their operations. This intelligence assists clients through all stages of business development, from product ideation and market approach strategies to the execution of sales and marketing campaigns. Definitive Healthcare’s innovative offerings support a wide range of industry stakeholders, including those in biopharmaceuticals, medical devices, healthcare IT, and more, enhancing their operational efficiency and market strategies.

Products and Services

Definitive Healthcare Corp provides a comprehensive suite of tools designed to meet the multifaceted needs of the healthcare ecosystem. The platform is meticulously segmented into functional areas tailored to enhance business operations across several domains:

  • Sales: Tools and insights to optimize sales strategies, identify potential clients, and understand market needs.
  • Marketing: Solutions that enable targeted marketing efforts, improve ROI on marketing campaigns, and enhance brand visibility within the healthcare sector.
  • Clinical Research and Product Development: Data and analytics to support research initiatives and product innovation, helping to streamline the development process and expedite time-to-market.
  • Strategy: Strategic insights that guide long-term planning, market entry strategies, and competitive positioning.
  • Talent Acquisition: Intelligence to assist in identifying and recruiting top talent within the healthcare industry, optimizing team capabilities and performance.
  • Physician Network Management: Comprehensive data on healthcare providers to manage and expand physician networks effectively, ensuring better patient coverage and service delivery.

Apart from serving key stakeholders in the biopharmaceutical, medical devices, and healthcare IT sectors, Definitive Healthcare’s offerings also cater to diversified companies, including those in staffing, commercial real estate, financial institutions, and other entities within the healthcare ecosystem. This broad service range underscores the company's role as a crucial ally in navigating the complexities of the healthcare market.

Contact Information

Address: 550 Cochituate Road
Phone: 508 720 4224